title: Pregnancy and heart disease.
abstract: The maternal cardiovascular system undergoes extensive changes during pregnancy. These changes become especially important in women with underlying cardiac disease. In order to provide a basis for understanding cardiac disease in pregnancy, the authors provide a discussion of the normal cardiovascular physiology of pregnancy, followed by a review of the types of heart disease in women of childbearing age.
authors.forename: R M
authors.initials: RM
authors.lastname: Lang
authors.forename: K M
authors.initials: KM
authors.lastname: Borow
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D001794:Blood Pressure; D002302:Cardiac Output; D009202:Cardiomyopathies / Q000503:physiopathology; D002316:Cardiotonic Agents / Q000627:therapeutic use; D036861:Delivery, Obstetric; D005260:Female; D005333:Fetus / Q000187:drug effects; D006330:Heart Defects, Congenital / Q000503:physiopathology; D006331:Heart Diseases / Q000503:physiopathology*; D006349:Heart Valve Diseases / Q000503:physiopathology; D006350:Heart Valve Prosthesis; D006439:Hemodynamics; D006801:Humans; D007231:Infant, Newborn; D007743:Labor, Obstetric; D008943:Mitral Valve; D010808:Physical Examination; D049590:Postpartum Period; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000503:physiopathology*
chemical_list: D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D002316:Cardiotonic Agents